BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

704 related articles for article (PubMed ID: 18979291)

  • 1. Enhanced systemic matrix metalloproteinase response in Helicobacter pylori gastritis.
    Rautelin HI; Oksanen AM; Veijola LI; Sipponen PI; Tervahartiala TI; Sorsa TA; Lauhio A
    Ann Med; 2009; 41(3):208-15. PubMed ID: 18979291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased production of matrix metalloproteinases in Helicobacter pylori-associated human gastritis.
    Bergin PJ; Anders E; Sicheng W; Erik J; Jennie A; Hans L; Pierre M; Qiang PH; Marianne QJ
    Helicobacter; 2004 Jun; 9(3):201-10. PubMed ID: 15165255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of systemic matrix metalloproteinase and their regulator response in children with Helicobacter pylori gastritis.
    Rautelin H; Tervahartiala T; Lauhio A; Sorsa T; Kolho KL
    Scand J Clin Lab Invest; 2010 Nov; 70(7):492-6. PubMed ID: 20854182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of cell-surface expression of matrix metalloproteinases and their inhibitors on gastric epithelium and infiltrating mucosal lymphocytes in progression of Helicobacter pylori-associated gastritis.
    Koyama S
    Scand J Gastroenterol; 2004 Nov; 39(11):1046-53. PubMed ID: 15545160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eradication of Helicobacter pylori infection favourably affects altered gastric mucosal MMP-9 levels.
    Kubben FJ; Sier CF; Schram MT; Witte AM; Veenendaal RA; van Duijn W; Verheijen JH; Hanemaaijer R; Lamers CB; Verspaget HW
    Helicobacter; 2007 Oct; 12(5):498-504. PubMed ID: 17760717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori induces matrix metalloproteinase-9 through activation of nuclear factor kappaB.
    Mori N; Sato H; Hayashibara T; Senba M; Geleziunas R; Wada A; Hirayama T; Yamamoto N
    Gastroenterology; 2003 Apr; 124(4):983-92. PubMed ID: 12671895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous up-regulation of matrix metalloproteinases 1, 2, 3, 7, 8, 9 and tissue inhibitors of metalloproteinases 1, 4 in serum of patients with chronic obstructive pulmonary disease.
    Navratilova Z; Zatloukal J; Kriegova E; Kolek V; Petrek M
    Respirology; 2012 Aug; 17(6):1006-12. PubMed ID: 22591289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum MMPs 7-9 and their inhibitors during glucocorticoid and anti-TNF-α therapy in pediatric inflammatory bowel disease.
    Mäkitalo L; Rintamäki H; Tervahartiala T; Sorsa T; Kolho KL
    Scand J Gastroenterol; 2012 Jul; 47(7):785-94. PubMed ID: 22519363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating matrix metalloproteinase-2 but not matrix metalloproteinase-3, matrix metalloproteinase-9, or tissue inhibitor of metalloproteinase-1 predicts outcome in patients with congestive heart failure.
    George J; Patal S; Wexler D; Roth A; Sheps D; Keren G
    Am Heart J; 2005 Sep; 150(3):484-7. PubMed ID: 16169329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smoking and matrix metalloproteinases, neutrophil elastase and myeloperoxidase in chronic periodontitis.
    Ozçaka O; Biçakci N; Pussinen P; Sorsa T; Köse T; Buduneli N
    Oral Dis; 2011 Jan; 17(1):68-76. PubMed ID: 20646231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of matrix metalloproteinases and their tissue inhibitor in the morphogenesis of chronic Helicobacter pylori-associated gastritis in children].
    Kazachkov EL; Kazimirova AA
    Arkh Patol; 2009; 71(4):43-5. PubMed ID: 19824429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host single nucleotide polymorphisms of MMP-9 -1562/TIMP-1 372 have gender differences in the risk of gastric intestinal metaplasia after Helicobacter pylori infection.
    Hung KH; Hung HW; Yang HB; Lu CC; Wu JJ; Sheu BS
    Helicobacter; 2009 Dec; 14(6):580-7. PubMed ID: 19889076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum TIMP-1, TIMP-2, and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon, and in normal controls.
    Young-Min SA; Beeton C; Laughton R; Plumpton T; Bartram S; Murphy G; Black C; Cawston TE
    Ann Rheum Dis; 2001 Sep; 60(9):846-51. PubMed ID: 11502611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of matrix metalloprotease-2, -7 and -9 on human colon, liver and bile duct cell lines by enteric and gastric Helicobacter species.
    Yanagisawa N; Geironson L; Al-Soud WA; Ljungh S
    FEMS Immunol Med Microbiol; 2005 May; 44(2):197-204. PubMed ID: 15866216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor marker potential of serum matrix metalloproteinases in patients with head and neck cancer.
    Kuropkat C; Plehn S; Herz U; Dünne AA; Renz H; Werner JA
    Anticancer Res; 2002; 22(4):2221-7. PubMed ID: 12174907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of cathepsin X in Helicobacter pylori gastritis and gastric cancer.
    Krueger S; Kalinski T; Hundertmark T; Wex T; Küster D; Peitz U; Ebert M; Nägler DK; Kellner U; Malfertheiner P; Naumann M; Röcken C; Roessner A
    J Pathol; 2005 Sep; 207(1):32-42. PubMed ID: 16025436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alterations of metalloproteinases and their inhibitors concentrations in peripheral blood in children with congenital heart disease undergoing cardiac surgery with cardiopulmonary bypass].
    Paśnik J; Cywińska-Bernas A; Moll J; Moll J; Sysa A; Zeman K
    Przegl Lek; 2009; 66(7):359-64. PubMed ID: 20043576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of matrix metalloproteinases in patients with Wegener's granulomatosis.
    Bjerkeli V; Halvorsen B; Damås JK; Nordøy I; Yndestad A; Aukrust P; Frøland SS
    Ann Rheum Dis; 2004 Dec; 63(12):1659-63. PubMed ID: 15547092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric gelatinase B/matrix metalloproteinase-9 is rapidly increased in Helicobacter felis-induced gastritis.
    Bergin PJ; Raghavan S; Svensson H; Starckx S; Van Aelst I; Gjertsson I; Opdenakker G; Quiding-Järbrink M
    FEMS Immunol Med Microbiol; 2008 Jan; 52(1):88-98. PubMed ID: 17995959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.
    Ahmed SH; Clark LL; Pennington WR; Webb CS; Bonnema DD; Leonardi AH; McClure CD; Spinale FG; Zile MR
    Circulation; 2006 May; 113(17):2089-96. PubMed ID: 16636176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.